Development of Alkylated Hydrazides as Highly Potent and Selective Class I Histone Deacetylase Inhibitors with T cell Modulatory Properties.
Journal
Journal of medicinal chemistry
ISSN: 1520-4804
Titre abrégé: J Med Chem
Pays: United States
ID NLM: 9716531
Informations de publication
Date de publication:
22 12 2022
22 12 2022
Historique:
pubmed:
1
12
2022
medline:
24
12
2022
entrez:
30
11
2022
Statut:
ppublish
Résumé
Histone deacetylases (HDACs) are epigenetic regulators and additionally control the activity of non-histone substrates. We recently demonstrated that inhibition of HDAC8 overexpressed in various of cancers reduces hepatocellular carcinoma tumorigenicity in a T cell-dependent manner. Here, we present alkylated hydrazide-based class I HDAC inhibitors in which the
Identifiants
pubmed: 36449385
doi: 10.1021/acs.jmedchem.2c01132
doi:
Substances chimiques
Histone Deacetylase Inhibitors
0
Repressor Proteins
0
Histone Deacetylases
EC 3.5.1.98
Hydrazines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM